Lupu R - Search Results

1

Fatty acid synthase (FASN) is a tumor-cell-intrinsic metabolic checkpoint restricting T-cell immunity.

Cuyàs E, Pedarra S, Verdura S, Pardo MA, Espin Garcia R, Serrano-Hervás E, Llop-Hernández À, Teixidor E, Bosch-Barrera J, López-Bonet E, Martin-Castillo B, Lupu R, Pujana MA, Sardanyès J, Alarcón T, Menendez JA. Cuyàs E, et al. Among authors: lupu r. Cell Death Discov. 2024 Sep 30;10(1):417. doi: 10.1038/s41420-024-02184-z. Cell Death Discov. 2024. PMID: 39349429 Free PMC article.

2

Fatty acid synthase (FASN) as a therapeutic target in breast cancer.

Menendez JA, Lupu R. Menendez JA, et al. Among authors: lupu r. Expert Opin Ther Targets. 2017 Nov;21(11):1001-1016. doi: 10.1080/14728222.2017.1381087. Epub 2017 Sep 21. Expert Opin Ther Targets. 2017. PMID: 28922023 Review.

3

Fatty acid synthase (FASN) regulates the mitochondrial priming of cancer cells.

Schroeder B, Vander Steen T, Espinoza I, Venkatapoorna CMK, Hu Z, Silva FM, Regan K, Cuyàs E, Meng XW, Verdura S, Arbusà A, Schneider PA, Flatten KS, Kemble G, Montero J, Kaufmann SH, Menendez JA, Lupu R. Schroeder B, et al. Among authors: lupu r. Cell Death Dis. 2021 Oct 21;12(11):977. doi: 10.1038/s41419-021-04262-x. Cell Death Dis. 2021. PMID: 34675185 Free PMC article.

4

Oncogenic properties of the endogenous fatty acid metabolism: molecular pathology of fatty acid synthase in cancer cells.

Menendez JA, Lupu R. Menendez JA, et al. Among authors: lupu r. Curr Opin Clin Nutr Metab Care. 2006 Jul;9(4):346-57. doi: 10.1097/01.mco.0000232893.21050.15. Curr Opin Clin Nutr Metab Care. 2006. PMID: 16778562 Review.

5

Mediterranean dietary traditions for the molecular treatment of human cancer: anti-oncogenic actions of the main olive oil's monounsaturated fatty acid oleic acid (18:1n-9).

Menendez JA, Lupu R. Menendez JA, et al. Among authors: lupu r. Curr Pharm Biotechnol. 2006 Dec;7(6):495-502. doi: 10.2174/138920106779116900. Curr Pharm Biotechnol. 2006. PMID: 17168666 Review.

6

Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis.

Menendez JA, Lupu R. Menendez JA, et al. Among authors: lupu r. Nat Rev Cancer. 2007 Oct;7(10):763-77. doi: 10.1038/nrc2222. Nat Rev Cancer. 2007. PMID: 17882277 Review.

7

The metastasis inducer CCN1 (CYR61) activates the fatty acid synthase (FASN)-driven lipogenic phenotype in breast cancer cells.

Menendez JA, Vellon L, Espinoza I, Lupu R. Menendez JA, et al. Among authors: lupu r. Oncoscience. 2016 Jul 22;3(7-8):242-257. doi: 10.18632/oncoscience.314. eCollection 2016. Oncoscience. 2016. PMID: 27713913 Free PMC article.

8

Clinical and therapeutic relevance of the metabolic oncogene fatty acid synthase in HER2+ breast cancer.

Corominas-Faja B, Vellon L, Cuyàs E, Buxó M, Martin-Castillo B, Serra D, García J, Lupu R, Menendez JA. Corominas-Faja B, et al. Among authors: lupu r. Histol Histopathol. 2017 Jul;32(7):687-698. doi: 10.14670/HH-11-830. Epub 2016 Oct 7. Histol Histopathol. 2017. PMID: 27714708 Free PMC article.

9

Fatty acid synthase regulates estrogen receptor-α signaling in breast cancer cells.

Menendez JA, Lupu R. Menendez JA, et al. Among authors: lupu r. Oncogenesis. 2017 Feb 27;6(2):e299. doi: 10.1038/oncsis.2017.4. Oncogenesis. 2017. PMID: 28240737 Free PMC article.

10

Tumor Cell-Intrinsic Immunometabolism and Precision Nutrition in Cancer Immunotherapy.

Cuyàs E, Verdura S, Martin-Castillo B, Alarcón T, Lupu R, Bosch-Barrera J, Menendez JA. Cuyàs E, et al. Among authors: lupu r. Cancers (Basel). 2020 Jul 2;12(7):1757. doi: 10.3390/cancers12071757. Cancers (Basel). 2020. PMID: 32630618 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

166 results

Search Page

Filters